comparemela.com

Page 15 - Longboard Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

Bexicaserin achieved a median seizure reduction of 53.3% in countable motor seizures compared to 20.8% in the placebo group across the DEE study population A median seizure reduction of 72.1% in.

Longboard s shares triple as epilepsy med halves seizures

Longboard s shares triple as epilepsy med halves seizures
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Longboard Pharmaceuticals (LBPH) Reports Positive Topline Data from the PACIFIC Study

Longboard Pharmaceuticals (LBPH) Reports Positive Topline Data from the PACIFIC Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Longboard stock soars 132% in premarket trading on positive data (NASDAQ:LBPH)

Longboard stock soars 132% in premarket trading on positive data (NASDAQ:LBPH)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Longboard Pharmaceuticals Stock (NASDAQ:LBPH), Quotes and News Summary

Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.